Clal Insurance’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.9M Buy
228,108
+77,970
+52% +$18.2M 0.26% 70
2026
Q1
$36.7M Buy
150,138
+149,979
+94,326% +$34.9M 0.22% 74
2025
Q4
$33K Sell
159
-31
-16% -$6.13K ﹤0.01% 141
2025
Q3
$35K Sell
190
-23
-11% -$3.94K ﹤0.01% 142
2025
Q2
$33K Sell
213
-179
-46% -$27.5K ﹤0.01% 137
2025
Q1
$65K Buy
392
+312
+390% +$48.8K ﹤0.01% 117
2024
Q4
$12K Buy
+80
New +$12.4K ﹤0.01% 112
2020
Q3
Sell
-3,000
Closed -$422K 152
2020
Q2
$422K Sell
3,000
-1,000
-25% -$146K 0.01% 120
2020
Q1
$526K Buy
4,000
+3,417
+586% +$485K 0.01% 103
2019
Q4
$4K Buy
+583
New +$79.1K ﹤0.01% 112

Other funds holding JNJ

Clal Insurance's JNJ Position: Q2 2026 in Review

Clal Insurance increased its Johnson & Johnson (JNJ) stake by 52% in Q2 2026, buying an estimated $18.2M and bringing the position to 228,108 shares worth $57.9M. The position accounts for 0.26% of the portfolio, ranked #70.

Clal Insurance first reported a position in JNJ in Q4 2019 and has held it in 10 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Clal Insurance held 228,108 shares of Johnson & Johnson worth $57.9M as of Q2 2026.
  • Clal Insurance bought 77,970 Johnson & Johnson shares in Q2 2026, an estimated $18.2M.
  • Johnson & Johnson made up 0.26% of Clal Insurance's portfolio in Q2 2026, its #70 holding.
  • Clal Insurance first reported a position in Johnson & Johnson in Q4 2019 and has held it in 10 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.